President Vladimir Putin Approves Establishment of "Russian Biological Industrial Company" Scientific-Production Association

President Vladimir Putin has signed a decree establishing the "Russian Biological Industrial Company," a new scientific and production association designed to consolidate and advance the nation's veterinary biopharmaceutical sector. The entity will consolidate several of the nation's key regional biofactories into a single, integrated research and production platform.

The decree, dated March 30, 2026, creates a fully state-owned joint-stock company named Scientific and Production Association "Russian Biological Industrial Company" (AO "NPO 'Russian Biological Industrial Company'"). This strategic move is aimed at ensuring technological independence, bolstering national biosecurity, and stimulating investment in veterinary medicine.
The new conglomerate's primary focus will be the development and production of veterinary vaccines and pharmaceuticals. Key priorities include:
Production of drugs for particularly dangerous animal diseases to support national anti-epizootic measures.
Conducting advanced R&D in veterinary science, biotechnology, and related fields, including the development and launch of novel biological products.

According to the Russian Ministry of Agriculture, this consolidation will bring together unique scientific competencies and modern production facilities. This synergy is expected to accelerate the development of cutting-edge solutions for the livestock industry, strengthen the domestic biopharmaceutical sector, and significantly enhance the technological foundation for animal health and food security in the country.

AGRAVIA and iAGRI: A Platform for Industry Advancement
This development aligns directly with the core thematic priorities of the AGRAVIA and iAGRI exhibitions. As leading international events for the agro-industrial sector, both exhibitions consistently highlight Feed Solutions, Veterinary Products, Compound Feed Equipment, and Laboratory Equipment as key pillars of the exhibition program. These dedicated sectors bring together leading manufacturers, suppliers, and industry experts to showcase innovations in animal nutrition, health management, and biosecurity — all of which are essential to supporting initiatives like the newly formed "Russian Biological Industrial Company." The exhibitions serve as a vital meeting point for stakeholders across the entire value chain, from research and development to practical on-farm application